ERBB2 and breast carcinoma: Similarly, there are morphological inclusion criteria for eligibility for transcriptomics analysis (e.g., gene expression profiling), where the predictive value is meaningful only in cases with specific breast cancer features (e.g., ER+, HER2−, etc.)[38].